A medicine used by millions of people around the world to manage type 2 diabetes is now being closely studied for a possible side effect involving vision.
New research from the University of Southern Denmark suggests that a drug called Ozempic may be linked to a rare but serious eye condition that can lead to permanent vision loss.
Ozempic is widely used to help people control their blood sugar levels. It has become especially popular in recent years because it not only helps manage diabetes but also supports weight loss.
For many patients, it has been seen as a very effective and helpful treatment. Doctors often prescribe it because it can also reduce the risk of other health problems related to diabetes, such as heart and kidney disease.
However, as with any medication, researchers continue to study its long-term safety. The new concern focuses on a condition called non-arteritic anterior ischemic optic neuropathy, or NAION. This condition occurs when the blood supply to the optic nerve is suddenly reduced.
The optic nerve plays a very important role because it carries visual information from the eye to the brain. When this nerve is damaged, it can cause sudden vision loss, and in many cases, the damage cannot be reversed.
NAION is considered a rare condition, but its effects can be very serious. People who develop it often notice a sudden loss of vision, usually in one eye. Because the vision loss can be permanent, it is important for doctors and researchers to understand what may increase the risk of this condition.
Earlier research in the United States had already suggested a possible link between Ozempic and NAION. That earlier study, which included fewer patients, found that people using the drug might have more than twice the risk of developing the condition. The new studies from Denmark and Norway provide stronger evidence because they include much larger groups of people.
In one of the studies, researchers looked at medical records from more than 424,000 people with type 2 diabetes. Among them, over 106,000 were using Ozempic. The results showed that people taking Ozempic were about twice as likely to develop NAION compared to those using other diabetes medications.
The researchers also noticed a change over time. Before Ozempic became widely used around 2018, Denmark reported about 60 to 70 cases of NAION each year.
In more recent years, that number has increased to around 150 cases per year. Many of these cases were found in people with type 2 diabetes, which raised further questions about a possible connection.
A second study focused on people who had just started using Ozempic and compared them with patients who had begun other diabetes treatments. This helped make the comparison more accurate. Once again, the results showed that people using Ozempic had about double the risk of developing NAION.
Even with these findings, experts are careful to point out that the overall risk is still very low. Most people who take Ozempic will never develop this eye condition. This is an important point because the benefits of the medication are well known. It helps control blood sugar and can protect against serious complications of diabetes.
Doctors say that treatment decisions should always be based on a balance between benefits and risks. For many patients, Ozempic may still be the best choice.
However, some people may need to think more carefully about their options. For example, patients who already have eye problems or who have previously had NAION in one eye may want to talk with their doctor about other treatments.
It is very important that patients do not stop taking their medication without medical advice. Stopping a diabetes drug suddenly can lead to serious health problems. Instead, anyone who has concerns should speak with a healthcare professional. If someone notices sudden changes in their vision, they should seek medical help right away.
These studies were published in the International Journal of Retina and Vitreous and were also shared as a preprint on medRxiv. The researchers hope their findings will help doctors make better decisions and improve patient safety.
This research reminds us that even well-known and widely used medicines need ongoing study. As scientists continue to collect and analyze data, they can better understand both the benefits and risks of treatments. This helps ensure that patients receive care that is not only effective but also as safe as possible.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
